Target intelligence / Profile preview

SLC25A51 pseudogene 2 (SLC25A51P2)

Target
SLC25A51P2
Molecular classification
Pseudogene, Other (not enzyme, transporter, receptor, etc.)
01

Overview

SLC25A51 pseudogene 2 (SLC25A51P2) is a human genomic locus classified as a pseudogene, meaning it is a non-functional copy of the SLC25A51 gene that is not translated into protein. While its parent gene, SLC25A51, encodes a mitochondrial carrier protein essential for NAD+ transport and mitochondrial metabolism, SLC25A51P2 does not produce a functional protein and lacks known physiological or pathological roles. It may be included in annotation sets and sometimes appears in gene catalogs, but is not considered a therapeutic target or relevant for drug development. The commonly searched SLC25A51 gene (without the "P2") is a functional mitochondrial NAD+ transporter and a potential research target, but SLC25A51P2 is a pseudogene, hence not a true target. There is no evidence that SLC25A51P2 is involved in disease, signal transduction, or any drug interaction. This entry should not be mistaken for the functional SLC25A51 transporter and should not be used for drug discovery or therapeutic targeting.

Other names
MCART4Pmitochondrial carrier triple repeat 4 pseudogenesolute carrier family 25 member 51 pseudogene 2SLC25A51P2
02

Biological functions

Other (no known biological function; not protein-coding)
03

Disease associations

Other (no known direct disease role as it does not code for a protein)

Beyond the preview

Go deeper on SLC25A51 pseudogene 2 (SLC25A51P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC25A51 pseudogene 2 (SLC25A51P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call